New "Skinhibitions(TM)" consumer marketing campaign to increase awareness about its proprietary Sublative(TM) technology offered in the eMatrix, eTwo and elos Plus Systems for both skin rejuvenation ...
Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today that it will begin the market launch of its proprietary Sublative technology for the removal or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback